Drug Shortage Report for ONDANSETRON INJECTION, USP
Report ID | 105793 |
Drug Identification Number | 02390051 |
Brand name | ONDANSETRON INJECTION, USP |
Common or Proper name | ONDANSETRON INJECTION, USP |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20ML 1VL |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2020-03-31 |
Actual start date | |
Estimated end date | 2020-05-12 |
Actual end date | 2020-04-01 |
Shortage status | Resolved |
Updated date | 2020-04-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-04-02 | French | Compare |
v7 | 2020-04-02 | English | Compare |
v6 | 2020-04-01 | English | Compare |
v5 | 2020-03-05 | French | Compare |
v4 | 2020-03-05 | English | Compare |
v3 | 2020-02-29 | English | Compare |
v2 | 2020-02-12 | French | Compare |
v1 | 2020-02-12 | English | Compare |
Showing 1 to 8 of 8